Accessibility settings

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/85764, first published .
Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Remote Management of Patients With Diabetic Macular Edema Receiving Long-Term Intravitreal Anti–Vascular Endothelial Growth Factor Therapy (RE-SHINE Study): Protocol for a Real-World Study

Authors of this article:

Shu Li1, 2 Author Orcid Image ;   Yupeng Xu2, 3 Author Orcid Image ;   Yan Xu2, 3 Author Orcid Image ;   Xun Xu2, 3 Author Orcid Image

Shu Li   1, 2 , PhD ;   Yupeng Xu   2, 3 , MD ;   Yan Xu   2, 3 , BMed ;   Xun Xu   2, 3 , MD

1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

2 National Clinical Research Center for Eye Diseases, Shanghai, China

3 Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Corresponding Author:

  • Xun Xu, MD
  • Department of Ophthalmology
  • Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
  • No. 85 Wujin Road, Hongkou District
  • Shanghai
  • China
  • Phone: 86 63240090
  • Email: drxuxun@sjtu.edu.cn